Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3490 Target Snapshot

11-beta-hydroxysteroid dehydrogenase type 2 · SINGLE PROTEIN · Mus musculus

362Compounds
25Assays
0Approved Drugs
324.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P51661. Use UniProt P51661 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P51661 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 11-beta-hydroxysteroid dehydrogenase type 2 as ChEMBL target CHEMBL3490, mapped to UniProt P51661. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
11-beta-hydroxysteroid dehydrogenase type 2
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3490
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P51661
11-beta-hydroxysteroid dehydrogenase type 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 11-beta-hydroxysteroid dehydrogenase type 2 is the right protein anchor across sources, using UniProt P51661 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label11-beta-hydroxysteroid dehydrogenase type 2
UniProt AccessionP51661
Component TypeProtein
Sequence Length386 aa

11-beta-hydroxysteroid dehydrogenase type 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 11-beta-hydroxysteroid dehydrogenase type 2, mapped to UniProt P51661. Sequence length is 386 aa.

Mapped IDP51661
Review name11-beta-hydroxysteroid dehydrogenase type 2
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

2
Phase II
Assay Mix

Activity Type Distribution

IC50320.0
EC504.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL499915 7.09 EC50 82.0 Clinical
CHEMBL499915 7.09 IC50 82.0 Clinical
CHEMBL246047 6.85 IC50 140.0 Preclinical
CHEMBL1761135 6.72 IC50 190.0 Preclinical
CHEMBL245647 6.27 IC50 540.0 Preclinical
CHEMBL376695 6.11 IC50 780.0 Preclinical
CHEMBL222365 5.96 IC50 1100.0 Preclinical
CHEMBL246678 5.92 IC50 1200.0 Preclinical
CHEMBL246888 5.92 IC50 1200.0 Preclinical
CHEMBL247286 5.82 IC50 1500.0 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
12
5.5
2
6.0
3
6.5
2
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

25
Total Assays
61
Tested Compounds
2
Assay Types
Binding — 24 assays, 61 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 16 55 5.0
cell-based format 7 6 6.7
assay format 1 0
ADME — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 1 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine